● Recruiting

Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Condition: Fallopian Tube Cancer · Ovarian Cancer · Primary Peritoneal · Sponsor: AstraZeneca

PhasePhase 1

Planned participants24

Who can joinFemale, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to assess the effect of itraconazole on the pharmacokinetics (PK) of AZ14170132.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (9)

Research Site	Batumi, Georgia	Not Yet Recruiting
Research Site	Tbilisi, Georgia	Not Yet Recruiting
Research Site	Tbilisi, Georgia	Not Yet Recruiting
Research Site	Dublin, Ireland	Recruiting
Research Site	Lisbon, Portugal	Recruiting
Research Site	Barcelona, Spain	Recruiting
Research Site	Logroño, Spain	Recruiting
Research Site	Madrid, Spain	Recruiting
Research Site	Madrid, Spain	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07402915